Search research articles
Contact Us
Filters
Showing results (81-90 of 116) with videos related to
Page
of 12
Sort By:
Cellular Immunology
|
October 1, 1980
Lymphocyte-induced production of prostaglandin E2 by tumor cells in vitro: requirements for direct contact and lymphocyte viability
K Owen, D Gomolka, M J Droller
Cellular Immunology
|
October 1, 1979
In vitro enhancement of natural and antibody-dependent lymphocyte-mediated cytotoxicity against tumor target cells by interferon
M J Droller, H Borg, P Perlmann
Cancer Research
|
September 1, 1980
Production of prostaglandin E2 by tumor cells in vitro
K Owen, D Gomolka, M J Droller
Urology
|
September 1, 1982
Prevention of cyclophosphamide-induced hemorrhagic cystitis
M J Droller, R Saral, G Santos
The Surgical Clinics of North America
|
October 1, 1988
Controversies in urologic oncology
A Kirschenbaum, N N Stone, M J Droller
Urology
|
July 1, 1988
Muscle-invasive bladder cancer: does it arise de novo or from pre-existing superficial disease?
L H Newman, M Tannenbaum, M J Droller
Cellular Immunology
|
August 1, 1978
A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells
M J Droller, M U Schneider, P Perlmann
The Journal of Urology
|
January 1, 1981
Studies of A, B or O (H) surface antigen specificity: carcinoma in situ and non-malignant lesions of the bladder
R C Emmott, M J Droller, N Javadpour
Cellular Immunology
|
August 1, 1978
Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells
M J Droller, P Perlmann, M U Schneider
Urologic Radiology
|
January 1, 1987
Ureteral and renal pelvic metastases from renal cell carcinoma
H A Mitty, M J Droller, S H Dikman
Page
of 12
Search research articles
Search
Showing results (81-90 of 116) with videos related to
Sort By:
Page
of 12
Cellular Immunology
|
October 1, 1980
Lymphocyte-induced production of prostaglandin E2 by tumor cells in vitro: requirements for direct contact and lymphocyte viability
K Owen, D Gomolka, M J Droller
Cellular Immunology
|
October 1, 1979
In vitro enhancement of natural and antibody-dependent lymphocyte-mediated cytotoxicity against tumor target cells by interferon
M J Droller, H Borg, P Perlmann
Cancer Research
|
September 1, 1980
Production of prostaglandin E2 by tumor cells in vitro
K Owen, D Gomolka, M J Droller
Urology
|
September 1, 1982
Prevention of cyclophosphamide-induced hemorrhagic cystitis
M J Droller, R Saral, G Santos
The Surgical Clinics of North America
|
October 1, 1988
Controversies in urologic oncology
A Kirschenbaum, N N Stone, M J Droller
Urology
|
July 1, 1988
Muscle-invasive bladder cancer: does it arise de novo or from pre-existing superficial disease?
L H Newman, M Tannenbaum, M J Droller
Cellular Immunology
|
August 1, 1978
A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells
M J Droller, M U Schneider, P Perlmann
The Journal of Urology
|
January 1, 1981
Studies of A, B or O (H) surface antigen specificity: carcinoma in situ and non-malignant lesions of the bladder
R C Emmott, M J Droller, N Javadpour
Cellular Immunology
|
August 1, 1978
Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells
M J Droller, P Perlmann, M U Schneider
Urologic Radiology
|
January 1, 1987
Ureteral and renal pelvic metastases from renal cell carcinoma
H A Mitty, M J Droller, S H Dikman
Page
of 12